CONMED Corporation to Exit Gastroenterology Product Lines
Dec 05, 2025
Contract Type
termination_agreement
Tampa BayManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage Recognition
Description
On December 5, 2025, CONMED Corporation announced its intent to exit its gastroenterology product lines, including the termination of its distribution agreement with W.L. Gore & Associates, Inc. for the Gore® VIABIL® biliary stent. This decision is part of the Company's portfolio optimization strategy
Company Information
Company
CONMED Corporation
Location
Tampa Bay, Florida, United States
About
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.